-
Shire LLC v. Colony Pharmaceuticals, Inc. et al DC
- 1:07-cv-00718
- D. Md.
- Judge: Catherine C. Blake
- Filed: 03/20/2007
- Closed: 04/17/2008
- Latest Docket Entry: 04/17/2008
- PACER
1
Plaintiff
3
Defendants
1
Accused
Product
3
Patents-in-Suit
395
Days in
Litigation
-
Shire LLC v. Colony Pharmaceuticals, Inc. et al DC
- 1:07-cv-00718
- D. Md.
- Judge: Catherine C. Blake
- Filed: 03/20/2007
- Closed: 04/17/2008
- Latest Docket Entry: 04/17/2008
- PACER
Cause of Action
Willful Patent Infringement
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
Patent Information
-
Infringement
Actavis Group
- 3 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| generic ADDERALL XR | US 6,322,819 B1 | All Asserted Claims |
Infringement
Entry 118
|
| generic ADDERALL XR | US 6,605,300 B1 | All Asserted Claims |
Infringement
Entry 118
|
| generic ADDERALL XR | US 6,913,768 B2 | All Asserted Claims |
Infringement
Entry 118
|
Actavis Incorporated
- 3 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| generic ADDERALL XR | US 6,322,819 B1 | All Asserted Claims |
Infringement
Entry 118
|
| generic ADDERALL XR | US 6,605,300 B1 | All Asserted Claims |
Infringement
Entry 118
|
| generic ADDERALL XR | US 6,913,768 B2 | All Asserted Claims |
Infringement
Entry 118
|
Colony Pharmaceuticals Incorporated
- 3 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| generic ADDERALL XR | US 6,322,819 B1 | All Asserted Claims |
Infringement
Entry 118
|
| generic ADDERALL XR | US 6,605,300 B1 | All Asserted Claims |
Infringement
Entry 118
|
| generic ADDERALL XR | US 6,913,768 B2 | All Asserted Claims |
Infringement
Entry 118
|